Search
for
Sort by
Research 211–240 of 1000+
- Hair Loss in Women
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- PCOS in adolescents
- Polycystic ovary syndrome and impact on health
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- Endocrine-skin interactions
- Acne in the adult female patient: a practical approach
- 11 Treatment of hirsutism and acne with cyproterone acetate
- Evidence-based approach to cutaneous hyperandrogenism in women
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Hirsutism: Diagnosis and management
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Polycystic ovary syndrome: A review for dermatologists
- Understanding and Management of Female Pattern Alopecia
- The Basic Science of Hair Biology
- Hormonal therapies for acne
- Hirsutism: diagnosis and treatment
- Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone)
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Hormone therapy in acne
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Contraception and the dermatologist